AADE Conference August 16-20th, 2018

By | 2018-08-09T17:09:40+00:00 August 9th, 2018|Uncategorized|

Join Eversense at the Annual AADE Conference, August 16-20th, 2018 in Baltimore, MD! We will have two exhibit locations, booth #811 and #465. Booth #811 will feature the Eversense CGM System, procedure demonstration, a fantastic line up of booth theater presentations (see the schedule below) and an introduction to Glo, our brand ambassador, and [...]

FDA Approves World’s First Long-Term Implantable Continuous Glucose Monitoring System for Marketing in United States

By | 2018-06-21T15:22:25+00:00 June 21st, 2018|Uncategorized|

FDA Approves World’s First Long-Term Implantable Continuous Glucose Monitoring System for Marketing in United States GERMANTOWN, Md., June 21, 2018 — Senseonics Holdings, Inc. (NYSE American: SENS) today announced the U.S. Food and Drug Administration has approved its Pre-market Approval (PMA) application to market the company’s Eversense® Continuous Glucose Monitoring (CGM) System to people with diabetes [...]